AbbVie Inc. 8-K Summary: Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of AbbVie Inc.'s Annual Meeting of Stockholders held on May 5, 2017. The filing details the voting outcomes for director elections, auditor ratification, executive compensation, and several governance proposals.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events and does not contain financial performance data.
Material Changes and Voting Outcomes
The following matters were submitted to a vote of security holders:
- Director Elections: Stockholders elected four Class II Directors (Robert J. Alpern, Edward M. Liddy, Melody B. Meyer, and Frederick H. Waddell) with terms expiring in 2020. All candidates received significant majority support.
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2017.
- Executive Compensation: Stockholders approved, on an advisory basis, the compensation of named executive officers.
- Annual Election of Directors Proposal: Stockholders did not approve the management proposal to amend the certificate of incorporation to provide for the annual election of directors. Votes were 1,116,988,345 For vs. 7,082,900 Against (excluding broker non-votes).
- Lobbying Report Proposal: Stockholders did not approve a stockholder proposal to issue a lobbying report.
- Separation of Chair and CEO: Stockholders did not approve a stockholder proposal to separate the positions of Chair and CEO.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the tabulation of votes cast at the annual meeting.
Key Facts for Investor Verification
- Management's proposal to move to annual director elections was rejected by stockholders.
- Stockholder proposals regarding a lobbying report and the separation of the Chair and CEO roles were rejected.
- Ernst & Young LLP was reappointed as the independent auditor.
- Significant broker non-votes (280,277,501 shares) were recorded for the director elections and executive compensation vote.